Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2022 | STEAP1 targeting CAR for adoptive cell therapy against cancer

Jon Amund Kyte, MD, PhD, University of Oslo, Oslo, Norway, discusses the development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer. STEAP1 CAR exhibits potent in vitro and in vivo functionality and can be further developed for potential clinical use. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.